Treatment of Radiation Proctitis in the Acute Setting
Acute radiation proctitis (ARP) occurs during or shortly after radiation therapy and requires prompt, targeted management to reduce symptoms and support ongoing cancer treatment.
Clinical scenario
This protocol addresses patients presenting with acute radiation proctitis — inflammatory rectal injury arising in the course of active radiation therapy. Management in the acute phase is distinct from the approach used for chronic or late-onset radiation injury.
Treatment approach
Management in this setting is primarily supportive. The regimen addresses symptom control and mucosal recovery through a combination of measures targeting hydration status and bowel function — one of which involves a luminal intervention to promote tissue healing.
The complete structured regimen, including all components and the criteria for therapy interruption, is available via the protocol below.
References
DOI: 10.5946/ce.2020.288
Acute radiation proctitis (ARP)
Treatment of patients with acute RP is usually supportive, consisting of hydration, anti-diarrheal agents, and butyrate enemas to promote tissue healing.
Approximately 20% of patients undergoing external beam radiation may require a short interruption of therapy.
View source ↗